Status:
UNKNOWN
Comparison of Free-breathing 3D Quantitative Perfusion in Patients With MINOCA and MINOCA-mimics
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
ETH Zurich
Conditions:
Myocardial Infarction With Non-Obstructive Coronary Artery
Myocarditis Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical study examines patients presenting with acute myocardial infarction and no significant coronary artery disease on coronary angiography (MINOCA) and patients with MINOCA-mimics with advan...
Detailed Description
Advanced CMR includes a novel free-breathing motion-informed locally low-rank quantitative 3D myocardial perfusion imaging. Perfusion imaging will be compared with 3D late gadolinium enhancement (LGE)...
Eligibility Criteria
Inclusion Criteria:
- acute presentation with signs/symptoms of acute coronary syndrome or myocarditis
- elevated cardiac biomarkers
- no signficant coronary artery disease on coronary angiogram or coronary CT
Exclusion Criteria:
- pacemaker/other devices or claustrophobia
- severe asthma, chronic obstructive lung or kidney disease
- acute pulmonary embolism
- arrhythmia on ECG
- moderate to severe valvular disease
Key Trial Info
Start Date :
June 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06323811
Start Date
June 15 2023
End Date
December 31 2025
Last Update
March 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091